nodes	percent_of_prediction	percent_of_DWPC	metapath
Glyburide—ABCC3—Fluorouracil—urinary bladder cancer	0.0491	0.0722	CbGbCtD
Glyburide—ABCC3—Cisplatin—urinary bladder cancer	0.0417	0.0613	CbGbCtD
Glyburide—ABCC3—Etoposide—urinary bladder cancer	0.041	0.0602	CbGbCtD
Glyburide—SLC22A7—Fluorouracil—urinary bladder cancer	0.0384	0.0564	CbGbCtD
Glyburide—ABCC1—Epirubicin—urinary bladder cancer	0.0323	0.0475	CbGbCtD
Glyburide—ABCB1—Mitomycin—urinary bladder cancer	0.0295	0.0434	CbGbCtD
Glyburide—ABCC3—Doxorubicin—urinary bladder cancer	0.0279	0.0411	CbGbCtD
Glyburide—ABCC3—Methotrexate—urinary bladder cancer	0.0271	0.0398	CbGbCtD
Glyburide—CFTR—vas deferens—urinary bladder cancer	0.0256	0.253	CbGeAlD
Glyburide—ABCC1—Etoposide—urinary bladder cancer	0.0252	0.037	CbGbCtD
Glyburide—ABCB11—Doxorubicin—urinary bladder cancer	0.0242	0.0355	CbGbCtD
Glyburide—ABCC2—Carboplatin—urinary bladder cancer	0.0222	0.0326	CbGbCtD
Glyburide—SLC22A7—Methotrexate—urinary bladder cancer	0.0212	0.0311	CbGbCtD
Glyburide—ABCG2—Fluorouracil—urinary bladder cancer	0.0202	0.0296	CbGbCtD
Glyburide—ABCG2—Carboplatin—urinary bladder cancer	0.0201	0.0295	CbGbCtD
Glyburide—ABCC2—Cisplatin—urinary bladder cancer	0.019	0.0279	CbGbCtD
Glyburide—ABCC2—Etoposide—urinary bladder cancer	0.0186	0.0274	CbGbCtD
Glyburide—ABCC1—Doxorubicin—urinary bladder cancer	0.0172	0.0252	CbGbCtD
Glyburide—ABCG2—Cisplatin—urinary bladder cancer	0.0171	0.0252	CbGbCtD
Glyburide—ABCG2—Etoposide—urinary bladder cancer	0.0168	0.0247	CbGbCtD
Glyburide—ABCC1—Methotrexate—urinary bladder cancer	0.0166	0.0244	CbGbCtD
Glyburide—SLCO1A2—Methotrexate—urinary bladder cancer	0.0148	0.0218	CbGbCtD
Glyburide—ALB—Fluorouracil—urinary bladder cancer	0.0139	0.0204	CbGbCtD
Glyburide—CYP3A4—Thiotepa—urinary bladder cancer	0.0134	0.0197	CbGbCtD
Glyburide—ABCC2—Doxorubicin—urinary bladder cancer	0.0127	0.0187	CbGbCtD
Glyburide—ABCC2—Methotrexate—urinary bladder cancer	0.0123	0.0181	CbGbCtD
Glyburide—ABCG2—Doxorubicin—urinary bladder cancer	0.0115	0.0169	CbGbCtD
Glyburide—ABCG2—Methotrexate—urinary bladder cancer	0.0111	0.0163	CbGbCtD
Glyburide—SLC22A6—Methotrexate—urinary bladder cancer	0.009	0.0132	CbGbCtD
Glyburide—ABCB1—Gemcitabine—urinary bladder cancer	0.0085	0.0125	CbGbCtD
Glyburide—ALB—Methotrexate—urinary bladder cancer	0.00767	0.0113	CbGbCtD
Glyburide—CYP2C9—Fluorouracil—urinary bladder cancer	0.00749	0.011	CbGbCtD
Glyburide—CYP2C9—Cisplatin—urinary bladder cancer	0.00637	0.00936	CbGbCtD
Glyburide—ABCB1—Cisplatin—urinary bladder cancer	0.00618	0.00908	CbGbCtD
Glyburide—ABCB1—Etoposide—urinary bladder cancer	0.00607	0.00892	CbGbCtD
Glyburide—ABCC8—penis—urinary bladder cancer	0.00595	0.0589	CbGeAlD
Glyburide—ABCB1—Doxorubicin—urinary bladder cancer	0.00414	0.00608	CbGbCtD
Glyburide—ABCB1—Methotrexate—urinary bladder cancer	0.00401	0.00589	CbGbCtD
Glyburide—CYP3A4—Etoposide—urinary bladder cancer	0.00364	0.00535	CbGbCtD
Glyburide—ABCC9—prostate gland—urinary bladder cancer	0.00357	0.0353	CbGeAlD
Glyburide—CPT1A—prostate gland—urinary bladder cancer	0.0026	0.0257	CbGeAlD
Glyburide—ABCC9—smooth muscle tissue—urinary bladder cancer	0.00253	0.025	CbGeAlD
Glyburide—CYP3A4—Doxorubicin—urinary bladder cancer	0.00248	0.00365	CbGbCtD
Glyburide—ABCA1—prostate gland—urinary bladder cancer	0.00242	0.024	CbGeAlD
Glyburide—CFTR—prostate gland—urinary bladder cancer	0.00228	0.0226	CbGeAlD
Glyburide—CYP2C19—urine—urinary bladder cancer	0.00228	0.0226	CbGeAlD
Glyburide—CFTR—seminal vesicle—urinary bladder cancer	0.00193	0.0191	CbGeAlD
Glyburide—CPT1A—renal system—urinary bladder cancer	0.00177	0.0175	CbGeAlD
Glyburide—CYP2C9—urine—urinary bladder cancer	0.00177	0.0175	CbGeAlD
Glyburide—KCNJ1—renal system—urinary bladder cancer	0.00173	0.0172	CbGeAlD
Glyburide—CFTR—epithelium—urinary bladder cancer	0.00168	0.0166	CbGeAlD
Glyburide—ABCA1—renal system—urinary bladder cancer	0.00165	0.0163	CbGeAlD
Glyburide—CFTR—renal system—urinary bladder cancer	0.00156	0.0154	CbGeAlD
Glyburide—ABCC8—prostate gland—urinary bladder cancer	0.00142	0.0141	CbGeAlD
Glyburide—CPT1A—female reproductive system—urinary bladder cancer	0.00142	0.014	CbGeAlD
Glyburide—CYP3A4—urine—urinary bladder cancer	0.00135	0.0134	CbGeAlD
Glyburide—ABCA1—female reproductive system—urinary bladder cancer	0.00132	0.0131	CbGeAlD
Glyburide—CPT1A—vagina—urinary bladder cancer	0.00128	0.0127	CbGeAlD
Glyburide—CFTR—female reproductive system—urinary bladder cancer	0.00125	0.0124	CbGeAlD
Glyburide—ABCC8—seminal vesicle—urinary bladder cancer	0.0012	0.0119	CbGeAlD
Glyburide—ABCA1—vagina—urinary bladder cancer	0.00119	0.0118	CbGeAlD
Glyburide—ABCC3—prostate gland—urinary bladder cancer	0.00119	0.0118	CbGeAlD
Glyburide—SLC22A7—renal system—urinary bladder cancer	0.00115	0.0114	CbGeAlD
Glyburide—ABCC9—lymph node—urinary bladder cancer	0.00114	0.0113	CbGeAlD
Glyburide—SLCO2B1—prostate gland—urinary bladder cancer	0.00111	0.011	CbGeAlD
Glyburide—Glipizide—PPARG—urinary bladder cancer	0.00111	0.578	CrCbGaD
Glyburide—ABCC8—smooth muscle tissue—urinary bladder cancer	0.00101	0.00996	CbGeAlD
Glyburide—SLC15A1—epithelium—urinary bladder cancer	0.000998	0.00988	CbGeAlD
Glyburide—ABCC8—renal system—urinary bladder cancer	0.000968	0.00959	CbGeAlD
Glyburide—ABCC2—prostate gland—urinary bladder cancer	0.000953	0.00944	CbGeAlD
Glyburide—SLC15A1—renal system—urinary bladder cancer	0.000925	0.00917	CbGeAlD
Glyburide—SLC15A2—prostate gland—urinary bladder cancer	0.000849	0.00841	CbGeAlD
Glyburide—KCNJ11—female reproductive system—urinary bladder cancer	0.000842	0.00834	CbGeAlD
Glyburide—ABCC1—prostate gland—urinary bladder cancer	0.000839	0.00831	CbGeAlD
Glyburide—CPT1A—lymph node—urinary bladder cancer	0.000829	0.00821	CbGeAlD
Glyburide—ABCC3—renal system—urinary bladder cancer	0.000813	0.00805	CbGeAlD
Glyburide—Bezafibrate—PPARG—urinary bladder cancer	0.000808	0.422	CrCbGaD
Glyburide—ABCA1—lymph node—urinary bladder cancer	0.000772	0.00765	CbGeAlD
Glyburide—SLCO2B1—renal system—urinary bladder cancer	0.000758	0.0075	CbGeAlD
Glyburide—SLC15A2—seminal vesicle—urinary bladder cancer	0.000718	0.00711	CbGeAlD
Glyburide—ABCC1—seminal vesicle—urinary bladder cancer	0.00071	0.00703	CbGeAlD
Glyburide—SLCO1A2—renal system—urinary bladder cancer	0.000697	0.00691	CbGeAlD
Glyburide—ABCG2—prostate gland—urinary bladder cancer	0.000695	0.00688	CbGeAlD
Glyburide—SLC15A1—vagina—urinary bladder cancer	0.00067	0.00664	CbGeAlD
Glyburide—ABCC3—female reproductive system—urinary bladder cancer	0.000651	0.00645	CbGeAlD
Glyburide—ABCC2—renal system—urinary bladder cancer	0.00065	0.00643	CbGeAlD
Glyburide—SLCO2B1—female reproductive system—urinary bladder cancer	0.000607	0.00601	CbGeAlD
Glyburide—ABCG2—seminal vesicle—urinary bladder cancer	0.000588	0.00582	CbGeAlD
Glyburide—SLC15A2—renal system—urinary bladder cancer	0.000579	0.00573	CbGeAlD
Glyburide—SLC15A2—urethra—urinary bladder cancer	0.000568	0.00563	CbGeAlD
Glyburide—ABCC1—urethra—urinary bladder cancer	0.000562	0.00557	CbGeAlD
Glyburide—ABCC2—female reproductive system—urinary bladder cancer	0.00052	0.00515	CbGeAlD
Glyburide—KCNJ11—lymph node—urinary bladder cancer	0.000492	0.00488	CbGeAlD
Glyburide—ABCG2—urethra—urinary bladder cancer	0.000465	0.00461	CbGeAlD
Glyburide—SLC15A2—female reproductive system—urinary bladder cancer	0.000463	0.00459	CbGeAlD
Glyburide—SLC15A2—vagina—urinary bladder cancer	0.000419	0.00415	CbGeAlD
Glyburide—ABCC1—vagina—urinary bladder cancer	0.000414	0.0041	CbGeAlD
Glyburide—CYP2C19—vagina—urinary bladder cancer	0.000404	0.004	CbGeAlD
Glyburide—ABCC3—lymph node—urinary bladder cancer	0.000381	0.00377	CbGeAlD
Glyburide—SLCO2B1—lymph node—urinary bladder cancer	0.000355	0.00352	CbGeAlD
Glyburide—CYP2C9—female reproductive system—urinary bladder cancer	0.000347	0.00343	CbGeAlD
Glyburide—ABCG2—vagina—urinary bladder cancer	0.000343	0.0034	CbGeAlD
Glyburide—ABCB1—prostate gland—urinary bladder cancer	0.000343	0.00339	CbGeAlD
Glyburide—CYP3A4—renal system—urinary bladder cancer	0.00033	0.00327	CbGeAlD
Glyburide—ALB—lymph node—urinary bladder cancer	0.000325	0.00322	CbGeAlD
Glyburide—ABCC2—lymph node—urinary bladder cancer	0.000304	0.00301	CbGeAlD
Glyburide—ABCB1—seminal vesicle—urinary bladder cancer	0.00029	0.00287	CbGeAlD
Glyburide—SLC15A2—lymph node—urinary bladder cancer	0.000271	0.00268	CbGeAlD
Glyburide—ABCC1—lymph node—urinary bladder cancer	0.000268	0.00265	CbGeAlD
Glyburide—CYP3A4—female reproductive system—urinary bladder cancer	0.000264	0.00262	CbGeAlD
Glyburide—ABCB1—epithelium—urinary bladder cancer	0.000252	0.00249	CbGeAlD
Glyburide—ABCB1—renal system—urinary bladder cancer	0.000234	0.00231	CbGeAlD
Glyburide—ABCB1—urethra—urinary bladder cancer	0.000229	0.00227	CbGeAlD
Glyburide—Leukopenia—Cisplatin—urinary bladder cancer	0.000227	0.00184	CcSEcCtD
Glyburide—Dermatitis bullous—Epirubicin—urinary bladder cancer	0.000226	0.00184	CcSEcCtD
Glyburide—Purpura—Epirubicin—urinary bladder cancer	0.000224	0.00182	CcSEcCtD
Glyburide—Vascular purpura—Doxorubicin—urinary bladder cancer	0.000223	0.00182	CcSEcCtD
Glyburide—Hepatic failure—Doxorubicin—urinary bladder cancer	0.000222	0.00181	CcSEcCtD
Glyburide—ABCG2—lymph node—urinary bladder cancer	0.000222	0.0022	CbGeAlD
Glyburide—Oedema—Gemcitabine—urinary bladder cancer	0.000222	0.0018	CcSEcCtD
Glyburide—Hypoglycaemia—Epirubicin—urinary bladder cancer	0.000221	0.0018	CcSEcCtD
Glyburide—Confusional state—Fluorouracil—urinary bladder cancer	0.00022	0.00179	CcSEcCtD
Glyburide—Convulsion—Cisplatin—urinary bladder cancer	0.000219	0.00178	CcSEcCtD
Glyburide—Oedema—Fluorouracil—urinary bladder cancer	0.000218	0.00177	CcSEcCtD
Glyburide—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.000217	0.00177	CcSEcCtD
Glyburide—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000217	0.00177	CcSEcCtD
Glyburide—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.000217	0.00177	CcSEcCtD
Glyburide—Hyponatraemia—Epirubicin—urinary bladder cancer	0.000217	0.00176	CcSEcCtD
Glyburide—Renal failure acute—Doxorubicin—urinary bladder cancer	0.000216	0.00176	CcSEcCtD
Glyburide—Diplopia—Epirubicin—urinary bladder cancer	0.000216	0.00176	CcSEcCtD
Glyburide—Myalgia—Cisplatin—urinary bladder cancer	0.000215	0.00175	CcSEcCtD
Glyburide—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000215	0.00175	CcSEcCtD
Glyburide—Anaemia—Etoposide—urinary bladder cancer	0.000214	0.00174	CcSEcCtD
Glyburide—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.000214	0.00174	CcSEcCtD
Glyburide—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.000214	0.00174	CcSEcCtD
Glyburide—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000213	0.00174	CcSEcCtD
Glyburide—Anorexia—Gemcitabine—urinary bladder cancer	0.000211	0.00172	CcSEcCtD
Glyburide—Renal impairment—Doxorubicin—urinary bladder cancer	0.00021	0.00171	CcSEcCtD
Glyburide—Urticaria—Thiotepa—urinary bladder cancer	0.000209	0.0017	CcSEcCtD
Glyburide—Dermatitis bullous—Doxorubicin—urinary bladder cancer	0.000209	0.0017	CcSEcCtD
Glyburide—Abdominal pain—Thiotepa—urinary bladder cancer	0.000208	0.00169	CcSEcCtD
Glyburide—Anorexia—Fluorouracil—urinary bladder cancer	0.000208	0.00169	CcSEcCtD
Glyburide—Leukopenia—Etoposide—urinary bladder cancer	0.000208	0.00169	CcSEcCtD
Glyburide—Purpura—Doxorubicin—urinary bladder cancer	0.000207	0.00169	CcSEcCtD
Glyburide—Hypotension—Gemcitabine—urinary bladder cancer	0.000207	0.00168	CcSEcCtD
Glyburide—Oedema—Cisplatin—urinary bladder cancer	0.000207	0.00168	CcSEcCtD
Glyburide—Hypoglycaemia—Doxorubicin—urinary bladder cancer	0.000205	0.00166	CcSEcCtD
Glyburide—Hypotension—Fluorouracil—urinary bladder cancer	0.000204	0.00166	CcSEcCtD
Glyburide—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000203	0.00165	CcSEcCtD
Glyburide—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000202	0.00165	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000202	0.00164	CcSEcCtD
Glyburide—Convulsion—Etoposide—urinary bladder cancer	0.000201	0.00163	CcSEcCtD
Glyburide—Hyponatraemia—Doxorubicin—urinary bladder cancer	0.0002	0.00163	CcSEcCtD
Glyburide—Diplopia—Doxorubicin—urinary bladder cancer	0.0002	0.00162	CcSEcCtD
Glyburide—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.0002	0.00162	CcSEcCtD
Glyburide—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000199	0.00162	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000199	0.00161	CcSEcCtD
Glyburide—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000198	0.00161	CcSEcCtD
Glyburide—Eosinophilia—Methotrexate—urinary bladder cancer	0.000197	0.00161	CcSEcCtD
Glyburide—Anorexia—Cisplatin—urinary bladder cancer	0.000197	0.0016	CcSEcCtD
Glyburide—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000196	0.00159	CcSEcCtD
Glyburide—Pancreatitis—Methotrexate—urinary bladder cancer	0.000195	0.00159	CcSEcCtD
Glyburide—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000194	0.00158	CcSEcCtD
Glyburide—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000194	0.00158	CcSEcCtD
Glyburide—Hypotension—Cisplatin—urinary bladder cancer	0.000193	0.00157	CcSEcCtD
Glyburide—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000193	0.00157	CcSEcCtD
Glyburide—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000192	0.00156	CcSEcCtD
Glyburide—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000191	0.00156	CcSEcCtD
Glyburide—Confusional state—Etoposide—urinary bladder cancer	0.000191	0.00155	CcSEcCtD
Glyburide—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000189	0.00154	CcSEcCtD
Glyburide—Pancytopenia—Methotrexate—urinary bladder cancer	0.000189	0.00154	CcSEcCtD
Glyburide—Asthenia—Thiotepa—urinary bladder cancer	0.000189	0.00154	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000188	0.00153	CcSEcCtD
Glyburide—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000188	0.00153	CcSEcCtD
Glyburide—Abdominal distension—Epirubicin—urinary bladder cancer	0.000188	0.00153	CcSEcCtD
Glyburide—ABCB1—female reproductive system—urinary bladder cancer	0.000187	0.00185	CbGeAlD
Glyburide—Pruritus—Thiotepa—urinary bladder cancer	0.000186	0.00152	CcSEcCtD
Glyburide—Paraesthesia—Cisplatin—urinary bladder cancer	0.000185	0.00151	CcSEcCtD
Glyburide—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000185	0.00151	CcSEcCtD
Glyburide—Eosinophilia—Epirubicin—urinary bladder cancer	0.000185	0.0015	CcSEcCtD
Glyburide—Dyspnoea—Cisplatin—urinary bladder cancer	0.000184	0.0015	CcSEcCtD
Glyburide—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000183	0.00149	CcSEcCtD
Glyburide—Pancreatitis—Epirubicin—urinary bladder cancer	0.000183	0.00149	CcSEcCtD
Glyburide—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000183	0.00149	CcSEcCtD
Glyburide—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.000182	0.00148	CcSEcCtD
Glyburide—Anorexia—Etoposide—urinary bladder cancer	0.00018	0.00147	CcSEcCtD
Glyburide—Diarrhoea—Thiotepa—urinary bladder cancer	0.00018	0.00147	CcSEcCtD
Glyburide—Decreased appetite—Cisplatin—urinary bladder cancer	0.00018	0.00146	CcSEcCtD
Glyburide—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00018	0.00146	CcSEcCtD
Glyburide—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000178	0.00145	CcSEcCtD
Glyburide—Pancytopenia—Epirubicin—urinary bladder cancer	0.000177	0.00144	CcSEcCtD
Glyburide—Hypotension—Etoposide—urinary bladder cancer	0.000177	0.00144	CcSEcCtD
Glyburide—Abdominal distension—Doxorubicin—urinary bladder cancer	0.000174	0.00141	CcSEcCtD
Glyburide—Urticaria—Fluorouracil—urinary bladder cancer	0.000173	0.00141	CcSEcCtD
Glyburide—Eosinophilia—Doxorubicin—urinary bladder cancer	0.000171	0.00139	CcSEcCtD
Glyburide—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.00017	0.00139	CcSEcCtD
Glyburide—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00017	0.00138	CcSEcCtD
Glyburide—Paraesthesia—Etoposide—urinary bladder cancer	0.00017	0.00138	CcSEcCtD
Glyburide—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000169	0.00138	CcSEcCtD
Glyburide—ABCB1—vagina—urinary bladder cancer	0.000169	0.00168	CbGeAlD
Glyburide—Dyspnoea—Etoposide—urinary bladder cancer	0.000169	0.00137	CcSEcCtD
Glyburide—Vomiting—Thiotepa—urinary bladder cancer	0.000167	0.00136	CcSEcCtD
Glyburide—Rash—Thiotepa—urinary bladder cancer	0.000166	0.00135	CcSEcCtD
Glyburide—Dermatitis—Thiotepa—urinary bladder cancer	0.000166	0.00135	CcSEcCtD
Glyburide—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000166	0.00135	CcSEcCtD
Glyburide—Headache—Thiotepa—urinary bladder cancer	0.000165	0.00134	CcSEcCtD
Glyburide—Decreased appetite—Etoposide—urinary bladder cancer	0.000164	0.00134	CcSEcCtD
Glyburide—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000164	0.00133	CcSEcCtD
Glyburide—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000163	0.00133	CcSEcCtD
Glyburide—Jaundice—Epirubicin—urinary bladder cancer	0.000162	0.00132	CcSEcCtD
Glyburide—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000161	0.00131	CcSEcCtD
Glyburide—Hepatitis—Methotrexate—urinary bladder cancer	0.00016	0.0013	CcSEcCtD
Glyburide—Asthenia—Gemcitabine—urinary bladder cancer	0.000159	0.00129	CcSEcCtD
Glyburide—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000158	0.00128	CcSEcCtD
Glyburide—Pruritus—Gemcitabine—urinary bladder cancer	0.000157	0.00128	CcSEcCtD
Glyburide—Nausea—Thiotepa—urinary bladder cancer	0.000156	0.00127	CcSEcCtD
Glyburide—Feeling abnormal—Etoposide—urinary bladder cancer	0.000156	0.00127	CcSEcCtD
Glyburide—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000155	0.00126	CcSEcCtD
Glyburide—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000155	0.00126	CcSEcCtD
Glyburide—Pruritus—Fluorouracil—urinary bladder cancer	0.000154	0.00125	CcSEcCtD
Glyburide—Visual impairment—Methotrexate—urinary bladder cancer	0.000154	0.00125	CcSEcCtD
Glyburide—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000152	0.00124	CcSEcCtD
Glyburide—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000152	0.00123	CcSEcCtD
Glyburide—Urticaria—Etoposide—urinary bladder cancer	0.00015	0.00122	CcSEcCtD
Glyburide—Jaundice—Doxorubicin—urinary bladder cancer	0.00015	0.00122	CcSEcCtD
Glyburide—Abdominal pain—Etoposide—urinary bladder cancer	0.00015	0.00122	CcSEcCtD
Glyburide—Hepatitis—Epirubicin—urinary bladder cancer	0.000149	0.00121	CcSEcCtD
Glyburide—Eye disorder—Methotrexate—urinary bladder cancer	0.000149	0.00121	CcSEcCtD
Glyburide—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000149	0.00121	CcSEcCtD
Glyburide—Asthenia—Cisplatin—urinary bladder cancer	0.000148	0.00121	CcSEcCtD
Glyburide—Visual impairment—Epirubicin—urinary bladder cancer	0.000144	0.00117	CcSEcCtD
Glyburide—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000144	0.00117	CcSEcCtD
Glyburide—Diarrhoea—Cisplatin—urinary bladder cancer	0.000141	0.00115	CcSEcCtD
Glyburide—Alopecia—Methotrexate—urinary bladder cancer	0.000141	0.00115	CcSEcCtD
Glyburide—Vomiting—Gemcitabine—urinary bladder cancer	0.000141	0.00115	CcSEcCtD
Glyburide—Rash—Gemcitabine—urinary bladder cancer	0.00014	0.00114	CcSEcCtD
Glyburide—Dermatitis—Gemcitabine—urinary bladder cancer	0.00014	0.00114	CcSEcCtD
Glyburide—Eye disorder—Epirubicin—urinary bladder cancer	0.00014	0.00114	CcSEcCtD
Glyburide—Hypersensitivity—Etoposide—urinary bladder cancer	0.000139	0.00113	CcSEcCtD
Glyburide—Malnutrition—Methotrexate—urinary bladder cancer	0.000139	0.00113	CcSEcCtD
Glyburide—Erythema—Methotrexate—urinary bladder cancer	0.000139	0.00113	CcSEcCtD
Glyburide—Headache—Gemcitabine—urinary bladder cancer	0.000139	0.00113	CcSEcCtD
Glyburide—Vomiting—Fluorouracil—urinary bladder cancer	0.000139	0.00113	CcSEcCtD
Glyburide—Hepatitis—Doxorubicin—urinary bladder cancer	0.000138	0.00112	CcSEcCtD
Glyburide—Rash—Fluorouracil—urinary bladder cancer	0.000137	0.00112	CcSEcCtD
Glyburide—Dermatitis—Fluorouracil—urinary bladder cancer	0.000137	0.00112	CcSEcCtD
Glyburide—Headache—Fluorouracil—urinary bladder cancer	0.000136	0.00111	CcSEcCtD
Glyburide—Asthenia—Etoposide—urinary bladder cancer	0.000136	0.0011	CcSEcCtD
Glyburide—Pruritus—Etoposide—urinary bladder cancer	0.000134	0.00109	CcSEcCtD
Glyburide—Visual impairment—Doxorubicin—urinary bladder cancer	0.000133	0.00108	CcSEcCtD
Glyburide—Alopecia—Epirubicin—urinary bladder cancer	0.000132	0.00107	CcSEcCtD
Glyburide—Nausea—Gemcitabine—urinary bladder cancer	0.000132	0.00107	CcSEcCtD
Glyburide—Vomiting—Cisplatin—urinary bladder cancer	0.000131	0.00107	CcSEcCtD
Glyburide—Vision blurred—Methotrexate—urinary bladder cancer	0.000131	0.00106	CcSEcCtD
Glyburide—Rash—Cisplatin—urinary bladder cancer	0.00013	0.00106	CcSEcCtD
Glyburide—Dermatitis—Cisplatin—urinary bladder cancer	0.00013	0.00106	CcSEcCtD
Glyburide—Malnutrition—Epirubicin—urinary bladder cancer	0.00013	0.00106	CcSEcCtD
Glyburide—Erythema—Epirubicin—urinary bladder cancer	0.00013	0.00106	CcSEcCtD
Glyburide—Diarrhoea—Etoposide—urinary bladder cancer	0.000129	0.00105	CcSEcCtD
Glyburide—Nausea—Fluorouracil—urinary bladder cancer	0.000129	0.00105	CcSEcCtD
Glyburide—Eye disorder—Doxorubicin—urinary bladder cancer	0.000129	0.00105	CcSEcCtD
Glyburide—Anaemia—Methotrexate—urinary bladder cancer	0.000128	0.00104	CcSEcCtD
Glyburide—Leukopenia—Methotrexate—urinary bladder cancer	0.000124	0.00101	CcSEcCtD
Glyburide—Nausea—Cisplatin—urinary bladder cancer	0.000123	0.000998	CcSEcCtD
Glyburide—Vision blurred—Epirubicin—urinary bladder cancer	0.000122	0.000996	CcSEcCtD
Glyburide—Alopecia—Doxorubicin—urinary bladder cancer	0.000122	0.000993	CcSEcCtD
Glyburide—Convulsion—Methotrexate—urinary bladder cancer	0.00012	0.000979	CcSEcCtD
Glyburide—Vomiting—Etoposide—urinary bladder cancer	0.00012	0.000979	CcSEcCtD
Glyburide—Erythema—Doxorubicin—urinary bladder cancer	0.00012	0.000978	CcSEcCtD
Glyburide—Malnutrition—Doxorubicin—urinary bladder cancer	0.00012	0.000978	CcSEcCtD
Glyburide—Anaemia—Epirubicin—urinary bladder cancer	0.00012	0.000977	CcSEcCtD
Glyburide—Rash—Etoposide—urinary bladder cancer	0.000119	0.000971	CcSEcCtD
Glyburide—Dermatitis—Etoposide—urinary bladder cancer	0.000119	0.00097	CcSEcCtD
Glyburide—Headache—Etoposide—urinary bladder cancer	0.000119	0.000964	CcSEcCtD
Glyburide—Arthralgia—Methotrexate—urinary bladder cancer	0.000118	0.000962	CcSEcCtD
Glyburide—Myalgia—Methotrexate—urinary bladder cancer	0.000118	0.000962	CcSEcCtD
Glyburide—Leukopenia—Epirubicin—urinary bladder cancer	0.000116	0.000946	CcSEcCtD
Glyburide—Confusional state—Methotrexate—urinary bladder cancer	0.000114	0.00093	CcSEcCtD
Glyburide—Vision blurred—Doxorubicin—urinary bladder cancer	0.000113	0.000922	CcSEcCtD
Glyburide—Convulsion—Epirubicin—urinary bladder cancer	0.000113	0.000916	CcSEcCtD
Glyburide—Nausea—Etoposide—urinary bladder cancer	0.000112	0.000914	CcSEcCtD
Glyburide—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000111	0.000904	CcSEcCtD
Glyburide—Anaemia—Doxorubicin—urinary bladder cancer	0.000111	0.000904	CcSEcCtD
Glyburide—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000111	0.000903	CcSEcCtD
Glyburide—Arthralgia—Epirubicin—urinary bladder cancer	0.000111	0.0009	CcSEcCtD
Glyburide—Myalgia—Epirubicin—urinary bladder cancer	0.000111	0.0009	CcSEcCtD
Glyburide—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00011	0.000891	CcSEcCtD
Glyburide—ABCB1—lymph node—urinary bladder cancer	0.000109	0.00108	CbGeAlD
Glyburide—Anorexia—Methotrexate—urinary bladder cancer	0.000108	0.000879	CcSEcCtD
Glyburide—Leukopenia—Doxorubicin—urinary bladder cancer	0.000108	0.000876	CcSEcCtD
Glyburide—Confusional state—Epirubicin—urinary bladder cancer	0.000107	0.00087	CcSEcCtD
Glyburide—Oedema—Epirubicin—urinary bladder cancer	0.000106	0.000863	CcSEcCtD
Glyburide—Hypotension—Methotrexate—urinary bladder cancer	0.000106	0.000862	CcSEcCtD
Glyburide—Shock—Epirubicin—urinary bladder cancer	0.000104	0.000849	CcSEcCtD
Glyburide—Convulsion—Doxorubicin—urinary bladder cancer	0.000104	0.000848	CcSEcCtD
Glyburide—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000104	0.000846	CcSEcCtD
Glyburide—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000104	0.000845	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000103	0.00084	CcSEcCtD
Glyburide—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000103	0.000834	CcSEcCtD
Glyburide—Myalgia—Doxorubicin—urinary bladder cancer	0.000102	0.000833	CcSEcCtD
Glyburide—Arthralgia—Doxorubicin—urinary bladder cancer	0.000102	0.000833	CcSEcCtD
Glyburide—Paraesthesia—Methotrexate—urinary bladder cancer	0.000102	0.000828	CcSEcCtD
Glyburide—Anorexia—Epirubicin—urinary bladder cancer	0.000101	0.000823	CcSEcCtD
Glyburide—Dyspnoea—Methotrexate—urinary bladder cancer	0.000101	0.000822	CcSEcCtD
Glyburide—Dyspepsia—Methotrexate—urinary bladder cancer	9.98e-05	0.000812	CcSEcCtD
Glyburide—Hypotension—Epirubicin—urinary bladder cancer	9.91e-05	0.000806	CcSEcCtD
Glyburide—Confusional state—Doxorubicin—urinary bladder cancer	9.9e-05	0.000805	CcSEcCtD
Glyburide—Decreased appetite—Methotrexate—urinary bladder cancer	9.85e-05	0.000802	CcSEcCtD
Glyburide—Oedema—Doxorubicin—urinary bladder cancer	9.81e-05	0.000798	CcSEcCtD
Glyburide—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	9.79e-05	0.000796	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	9.66e-05	0.000786	CcSEcCtD
Glyburide—Shock—Doxorubicin—urinary bladder cancer	9.66e-05	0.000786	CcSEcCtD
Glyburide—Nervous system disorder—Doxorubicin—urinary bladder cancer	9.62e-05	0.000783	CcSEcCtD
Glyburide—Thrombocytopenia—Doxorubicin—urinary bladder cancer	9.61e-05	0.000782	CcSEcCtD
Glyburide—Paraesthesia—Epirubicin—urinary bladder cancer	9.52e-05	0.000775	CcSEcCtD
Glyburide—Hyperhidrosis—Doxorubicin—urinary bladder cancer	9.49e-05	0.000772	CcSEcCtD
Glyburide—Dyspnoea—Epirubicin—urinary bladder cancer	9.46e-05	0.000769	CcSEcCtD
Glyburide—Anorexia—Doxorubicin—urinary bladder cancer	9.35e-05	0.000761	CcSEcCtD
Glyburide—Feeling abnormal—Methotrexate—urinary bladder cancer	9.34e-05	0.00076	CcSEcCtD
Glyburide—Dyspepsia—Epirubicin—urinary bladder cancer	9.34e-05	0.00076	CcSEcCtD
Glyburide—Gastrointestinal pain—Methotrexate—urinary bladder cancer	9.27e-05	0.000754	CcSEcCtD
Glyburide—Decreased appetite—Epirubicin—urinary bladder cancer	9.22e-05	0.00075	CcSEcCtD
Glyburide—Hypotension—Doxorubicin—urinary bladder cancer	9.17e-05	0.000746	CcSEcCtD
Glyburide—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	9.16e-05	0.000745	CcSEcCtD
Glyburide—Urticaria—Methotrexate—urinary bladder cancer	9e-05	0.000733	CcSEcCtD
Glyburide—Abdominal pain—Methotrexate—urinary bladder cancer	8.96e-05	0.000729	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	8.94e-05	0.000727	CcSEcCtD
Glyburide—Paraesthesia—Doxorubicin—urinary bladder cancer	8.81e-05	0.000717	CcSEcCtD
Glyburide—Dyspnoea—Doxorubicin—urinary bladder cancer	8.75e-05	0.000712	CcSEcCtD
Glyburide—Feeling abnormal—Epirubicin—urinary bladder cancer	8.74e-05	0.000711	CcSEcCtD
Glyburide—Gastrointestinal pain—Epirubicin—urinary bladder cancer	8.67e-05	0.000706	CcSEcCtD
Glyburide—Dyspepsia—Doxorubicin—urinary bladder cancer	8.64e-05	0.000703	CcSEcCtD
Glyburide—Decreased appetite—Doxorubicin—urinary bladder cancer	8.53e-05	0.000694	CcSEcCtD
Glyburide—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	8.47e-05	0.000689	CcSEcCtD
Glyburide—Urticaria—Epirubicin—urinary bladder cancer	8.43e-05	0.000686	CcSEcCtD
Glyburide—Abdominal pain—Epirubicin—urinary bladder cancer	8.38e-05	0.000682	CcSEcCtD
Glyburide—Hypersensitivity—Methotrexate—urinary bladder cancer	8.35e-05	0.000679	CcSEcCtD
Glyburide—Asthenia—Methotrexate—urinary bladder cancer	8.13e-05	0.000662	CcSEcCtD
Glyburide—Feeling abnormal—Doxorubicin—urinary bladder cancer	8.09e-05	0.000658	CcSEcCtD
Glyburide—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	8.03e-05	0.000653	CcSEcCtD
Glyburide—Pruritus—Methotrexate—urinary bladder cancer	8.02e-05	0.000652	CcSEcCtD
Glyburide—Hypersensitivity—Epirubicin—urinary bladder cancer	7.81e-05	0.000636	CcSEcCtD
Glyburide—Urticaria—Doxorubicin—urinary bladder cancer	7.8e-05	0.000634	CcSEcCtD
Glyburide—Abdominal pain—Doxorubicin—urinary bladder cancer	7.76e-05	0.000631	CcSEcCtD
Glyburide—Diarrhoea—Methotrexate—urinary bladder cancer	7.75e-05	0.000631	CcSEcCtD
Glyburide—Asthenia—Epirubicin—urinary bladder cancer	7.61e-05	0.000619	CcSEcCtD
Glyburide—Pruritus—Epirubicin—urinary bladder cancer	7.5e-05	0.000611	CcSEcCtD
Glyburide—Diarrhoea—Epirubicin—urinary bladder cancer	7.26e-05	0.00059	CcSEcCtD
Glyburide—Hypersensitivity—Doxorubicin—urinary bladder cancer	7.23e-05	0.000588	CcSEcCtD
Glyburide—Vomiting—Methotrexate—urinary bladder cancer	7.21e-05	0.000586	CcSEcCtD
Glyburide—Rash—Methotrexate—urinary bladder cancer	7.15e-05	0.000581	CcSEcCtD
Glyburide—Dermatitis—Methotrexate—urinary bladder cancer	7.14e-05	0.000581	CcSEcCtD
Glyburide—Headache—Methotrexate—urinary bladder cancer	7.1e-05	0.000578	CcSEcCtD
Glyburide—Asthenia—Doxorubicin—urinary bladder cancer	7.04e-05	0.000573	CcSEcCtD
Glyburide—Pruritus—Doxorubicin—urinary bladder cancer	6.94e-05	0.000565	CcSEcCtD
Glyburide—Vomiting—Epirubicin—urinary bladder cancer	6.74e-05	0.000549	CcSEcCtD
Glyburide—Nausea—Methotrexate—urinary bladder cancer	6.73e-05	0.000548	CcSEcCtD
Glyburide—Diarrhoea—Doxorubicin—urinary bladder cancer	6.71e-05	0.000546	CcSEcCtD
Glyburide—Rash—Epirubicin—urinary bladder cancer	6.69e-05	0.000544	CcSEcCtD
Glyburide—Dermatitis—Epirubicin—urinary bladder cancer	6.68e-05	0.000544	CcSEcCtD
Glyburide—Headache—Epirubicin—urinary bladder cancer	6.64e-05	0.000541	CcSEcCtD
Glyburide—Nausea—Epirubicin—urinary bladder cancer	6.3e-05	0.000513	CcSEcCtD
Glyburide—Vomiting—Doxorubicin—urinary bladder cancer	6.24e-05	0.000508	CcSEcCtD
Glyburide—Rash—Doxorubicin—urinary bladder cancer	6.19e-05	0.000503	CcSEcCtD
Glyburide—Dermatitis—Doxorubicin—urinary bladder cancer	6.18e-05	0.000503	CcSEcCtD
Glyburide—Headache—Doxorubicin—urinary bladder cancer	6.15e-05	0.0005	CcSEcCtD
Glyburide—Nausea—Doxorubicin—urinary bladder cancer	5.83e-05	0.000474	CcSEcCtD
Glyburide—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	1.6e-05	0.00017	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	1.59e-05	0.000169	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	1.58e-05	0.000169	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—TYMS—urinary bladder cancer	1.58e-05	0.000168	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.57e-05	0.000168	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—PTEN—urinary bladder cancer	1.57e-05	0.000167	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—PTEN—urinary bladder cancer	1.57e-05	0.000167	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PRSS3—urinary bladder cancer	1.56e-05	0.000166	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—GSTM1—urinary bladder cancer	1.56e-05	0.000166	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—NCOR1—urinary bladder cancer	1.56e-05	0.000166	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—NQO1—urinary bladder cancer	1.53e-05	0.000163	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	1.53e-05	0.000163	CbGpPWpGaD
Glyburide—ABCG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.51e-05	0.000161	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—TYMS—urinary bladder cancer	1.51e-05	0.000161	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—EP300—urinary bladder cancer	1.5e-05	0.00016	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—EP300—urinary bladder cancer	1.5e-05	0.00016	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	1.5e-05	0.000159	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—GSTM1—urinary bladder cancer	1.49e-05	0.000159	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—NCOR1—urinary bladder cancer	1.49e-05	0.000159	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—GPX1—urinary bladder cancer	1.49e-05	0.000159	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.48e-05	0.000158	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	1.48e-05	0.000157	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	1.47e-05	0.000157	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—ERCC2—urinary bladder cancer	1.47e-05	0.000156	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	1.46e-05	0.000155	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.44e-05	0.000153	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—GPX1—urinary bladder cancer	1.43e-05	0.000153	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.43e-05	0.000152	CbGpPWpGaD
Glyburide—ALB—Metabolism—TYMP—urinary bladder cancer	1.42e-05	0.000152	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—GSTP1—urinary bladder cancer	1.42e-05	0.000151	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PPARG—urinary bladder cancer	1.41e-05	0.000151	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—ERCC2—urinary bladder cancer	1.4e-05	0.00015	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	1.4e-05	0.00015	CbGpPWpGaD
Glyburide—ABCC1—Disease—NCOR1—urinary bladder cancer	1.4e-05	0.000149	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	1.39e-05	0.000148	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—MTHFR—urinary bladder cancer	1.38e-05	0.000147	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PPARG—urinary bladder cancer	1.37e-05	0.000146	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.37e-05	0.000146	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.37e-05	0.000146	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	1.37e-05	0.000146	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—CREBBP—urinary bladder cancer	1.36e-05	0.000145	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—NQO1—urinary bladder cancer	1.34e-05	0.000143	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	1.34e-05	0.000143	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—MTHFR—urinary bladder cancer	1.32e-05	0.000141	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—TYMS—urinary bladder cancer	1.32e-05	0.00014	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—CREBBP—urinary bladder cancer	1.32e-05	0.00014	CbGpPWpGaD
Glyburide—ABCC1—Disease—ERCC2—urinary bladder cancer	1.31e-05	0.00014	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PLAU—urinary bladder cancer	1.31e-05	0.00014	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—NCOR1—urinary bladder cancer	1.3e-05	0.000139	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—GSTM1—urinary bladder cancer	1.3e-05	0.000139	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.29e-05	0.000138	CbGpPWpGaD
Glyburide—ALB—Metabolism—NAT2—urinary bladder cancer	1.29e-05	0.000137	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.28e-05	0.000137	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—TYMP—urinary bladder cancer	1.28e-05	0.000136	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—GSTP1—urinary bladder cancer	1.27e-05	0.000136	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	1.27e-05	0.000135	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NAT1—urinary bladder cancer	1.27e-05	0.000135	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—TYMP—urinary bladder cancer	1.25e-05	0.000133	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—GPX1—urinary bladder cancer	1.25e-05	0.000133	CbGpPWpGaD
Glyburide—ABCC1—Disease—MTHFR—urinary bladder cancer	1.24e-05	0.000132	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.23e-05	0.000131	CbGpPWpGaD
Glyburide—ABCC1—Disease—TERT—urinary bladder cancer	1.23e-05	0.000131	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.23e-05	0.000131	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	1.22e-05	0.00013	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—ERCC2—urinary bladder cancer	1.22e-05	0.00013	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	1.2e-05	0.000128	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—TYMS—urinary bladder cancer	1.18e-05	0.000126	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—GSTM1—urinary bladder cancer	1.17e-05	0.000125	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—NCOR1—urinary bladder cancer	1.17e-05	0.000125	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.17e-05	0.000125	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—TYMP—urinary bladder cancer	1.17e-05	0.000124	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	1.16e-05	0.000124	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—NAT2—urinary bladder cancer	1.16e-05	0.000123	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—MTHFR—urinary bladder cancer	1.15e-05	0.000123	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	1.14e-05	0.000122	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	1.13e-05	0.000121	CbGpPWpGaD
Glyburide—ABCC1—Disease—FGFR3—urinary bladder cancer	1.13e-05	0.000121	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—NAT2—urinary bladder cancer	1.13e-05	0.00012	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—GPX1—urinary bladder cancer	1.12e-05	0.00012	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—GSTP1—urinary bladder cancer	1.12e-05	0.00012	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.12e-05	0.000119	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PPARG—urinary bladder cancer	1.12e-05	0.000119	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PTGS2—urinary bladder cancer	1.11e-05	0.000118	CbGpPWpGaD
Glyburide—ALB—Metabolism—RRM2—urinary bladder cancer	1.11e-05	0.000118	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—ERCC2—urinary bladder cancer	1.1e-05	0.000117	CbGpPWpGaD
Glyburide—ALB—Hemostasis—CREBBP—urinary bladder cancer	1.08e-05	0.000115	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PTGS2—urinary bladder cancer	1.08e-05	0.000115	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—CREBBP—urinary bladder cancer	1.07e-05	0.000114	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PPARG—urinary bladder cancer	1.07e-05	0.000114	CbGpPWpGaD
Glyburide—ALB—Hemostasis—IGF1—urinary bladder cancer	1.07e-05	0.000114	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—NAT2—urinary bladder cancer	1.05e-05	0.000112	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.04e-05	0.000111	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—TYMS—urinary bladder cancer	1.04e-05	0.000111	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—MTHFR—urinary bladder cancer	1.03e-05	0.00011	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—GSTM1—urinary bladder cancer	1.03e-05	0.00011	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—NCOR1—urinary bladder cancer	1.03e-05	0.00011	CbGpPWpGaD
Glyburide—ALB—Metabolism—HPGDS—urinary bladder cancer	1.03e-05	0.00011	CbGpPWpGaD
Glyburide—ALB—Metabolism—ENO2—urinary bladder cancer	1.03e-05	0.00011	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—CREBBP—urinary bladder cancer	1.03e-05	0.00011	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.02e-05	0.000109	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.01e-05	0.000107	CbGpPWpGaD
Glyburide—ALB—Metabolism—GSTT1—urinary bladder cancer	9.98e-06	0.000106	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—RRM2—urinary bladder cancer	9.97e-06	0.000106	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—GPX1—urinary bladder cancer	9.87e-06	0.000105	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	9.86e-06	0.000105	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	9.83e-06	0.000105	CbGpPWpGaD
Glyburide—ALB—Hemostasis—RHOA—urinary bladder cancer	9.77e-06	0.000104	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—RRM2—urinary bladder cancer	9.74e-06	0.000104	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PTEN—urinary bladder cancer	9.69e-06	0.000103	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—ERCC2—urinary bladder cancer	9.69e-06	0.000103	CbGpPWpGaD
Glyburide—ABCC1—Disease—CREBBP—urinary bladder cancer	9.63e-06	0.000103	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	9.61e-06	0.000102	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PTEN—urinary bladder cancer	9.4e-06	0.0001	CbGpPWpGaD
Glyburide—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	9.34e-06	9.96e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	9.32e-06	9.94e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—EP300—urinary bladder cancer	9.24e-06	9.86e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	9.24e-06	9.85e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ENO2—urinary bladder cancer	9.24e-06	9.85e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	9.18e-06	9.79e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—MTHFR—urinary bladder cancer	9.11e-06	9.71e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—RRM2—urinary bladder cancer	9.09e-06	9.7e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—HPGDS—urinary bladder cancer	9.02e-06	9.61e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ENO2—urinary bladder cancer	9.02e-06	9.61e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—EP300—urinary bladder cancer	8.96e-06	9.56e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	8.96e-06	9.55e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	8.96e-06	9.55e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	8.82e-06	9.4e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PTGS2—urinary bladder cancer	8.79e-06	9.37e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GSTT1—urinary bladder cancer	8.75e-06	9.32e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—RHOA—urinary bladder cancer	8.71e-06	9.28e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PTGS2—urinary bladder cancer	8.42e-06	8.98e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	8.42e-06	8.98e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ENO2—urinary bladder cancer	8.42e-06	8.98e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PPARG—urinary bladder cancer	8.39e-06	8.95e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	8.37e-06	8.93e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—NQO1—urinary bladder cancer	8.29e-06	8.84e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—IL2—urinary bladder cancer	8.19e-06	8.73e-05	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	8.19e-06	8.73e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	8.17e-06	8.71e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—CREBBP—urinary bladder cancer	8.06e-06	8.59e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—ERBB2—urinary bladder cancer	8.06e-06	8.59e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	8.05e-06	8.58e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	8.04e-06	8.58e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PTGS2—urinary bladder cancer	7.88e-06	8.4e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—TYMP—urinary bladder cancer	7.68e-06	8.19e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PTEN—urinary bladder cancer	7.66e-06	8.17e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—NQO1—urinary bladder cancer	7.45e-06	7.94e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PPARG—urinary bladder cancer	7.38e-06	7.87e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—EP300—urinary bladder cancer	7.35e-06	7.84e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PTEN—urinary bladder cancer	7.35e-06	7.83e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	7.34e-06	7.82e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—EP300—urinary bladder cancer	7.31e-06	7.79e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—NQO1—urinary bladder cancer	7.27e-06	7.75e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	7.22e-06	7.7e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—SRC—urinary bladder cancer	7.15e-06	7.62e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—CREBBP—urinary bladder cancer	7.09e-06	7.56e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.02e-06	7.48e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—EP300—urinary bladder cancer	7.01e-06	7.47e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NAT2—urinary bladder cancer	6.95e-06	7.41e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GSTP1—urinary bladder cancer	6.92e-06	7.38e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—CDKN1A—urinary bladder cancer	6.89e-06	7.34e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PTEN—urinary bladder cancer	6.87e-06	7.33e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—NQO1—urinary bladder cancer	6.79e-06	7.24e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.69e-06	7.14e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PTGS2—urinary bladder cancer	6.6e-06	7.04e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.59e-06	7.02e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—EP300—urinary bladder cancer	6.56e-06	6.99e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—TYMS—urinary bladder cancer	6.43e-06	6.86e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	6.4e-06	6.82e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—SRC—urinary bladder cancer	6.37e-06	6.8e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—NCOR1—urinary bladder cancer	6.36e-06	6.78e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GSTM1—urinary bladder cancer	6.36e-06	6.78e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	6.3e-06	6.72e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	6.21e-06	6.62e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—EP300—urinary bladder cancer	6.1e-06	6.5e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GPX1—urinary bladder cancer	6.09e-06	6.49e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GSTP1—urinary bladder cancer	6.06e-06	6.46e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.01e-06	6.41e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—RRM2—urinary bladder cancer	6e-06	6.39e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—ERCC2—urinary bladder cancer	5.98e-06	6.37e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—KRAS—urinary bladder cancer	5.92e-06	6.31e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PTGS2—urinary bladder cancer	5.81e-06	6.19e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—TYMS—urinary bladder cancer	5.77e-06	6.15e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PTEN—urinary bladder cancer	5.76e-06	6.14e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.74e-06	6.12e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MYC—urinary bladder cancer	5.71e-06	6.09e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	5.71e-06	6.08e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	5.71e-06	6.08e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	5.66e-06	6.04e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—TYMS—urinary bladder cancer	5.64e-06	6.01e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—MTHFR—urinary bladder cancer	5.62e-06	5.99e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—EGFR—urinary bladder cancer	5.59e-06	5.96e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GSTM1—urinary bladder cancer	5.57e-06	5.94e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—NCOR1—urinary bladder cancer	5.57e-06	5.94e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	5.55e-06	5.92e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ENO2—urinary bladder cancer	5.55e-06	5.92e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—EP300—urinary bladder cancer	5.49e-06	5.85e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.48e-06	5.84e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GPX1—urinary bladder cancer	5.47e-06	5.83e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	5.39e-06	5.74e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	5.37e-06	5.72e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GPX1—urinary bladder cancer	5.33e-06	5.69e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—KRAS—urinary bladder cancer	5.28e-06	5.63e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—TYMS—urinary bladder cancer	5.26e-06	5.61e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—TP53—urinary bladder cancer	5.26e-06	5.61e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ERCC2—urinary bladder cancer	5.24e-06	5.58e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	5.2e-06	5.55e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	5.2e-06	5.55e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PTEN—urinary bladder cancer	5.07e-06	5.4e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	5.04e-06	5.38e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—HRAS—urinary bladder cancer	5.03e-06	5.36e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GPX1—urinary bladder cancer	4.98e-06	5.31e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—MTHFR—urinary bladder cancer	4.92e-06	5.25e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	4.89e-06	5.22e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—EP300—urinary bladder cancer	4.83e-06	5.15e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	4.6e-06	4.9e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PPARG—urinary bladder cancer	4.56e-06	4.86e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—HRAS—urinary bladder cancer	4.49e-06	4.78e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NQO1—urinary bladder cancer	4.48e-06	4.77e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CREBBP—urinary bladder cancer	4.38e-06	4.67e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PPARG—urinary bladder cancer	4.09e-06	4.36e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PPARG—urinary bladder cancer	3.99e-06	4.26e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	3.93e-06	4.19e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CREBBP—urinary bladder cancer	3.83e-06	4.09e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	3.73e-06	3.98e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PPARG—urinary bladder cancer	3.73e-06	3.98e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PTGS2—urinary bladder cancer	3.58e-06	3.82e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	3.58e-06	3.82e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—TYMS—urinary bladder cancer	3.47e-06	3.7e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	3.43e-06	3.66e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	3.43e-06	3.66e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GPX1—urinary bladder cancer	3.29e-06	3.5e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	3.23e-06	3.44e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	3.22e-06	3.43e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PTGS2—urinary bladder cancer	3.14e-06	3.35e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PTEN—urinary bladder cancer	3.13e-06	3.33e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	3.03e-06	3.23e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—EP300—urinary bladder cancer	2.98e-06	3.18e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	2.93e-06	3.13e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PTEN—urinary bladder cancer	2.81e-06	2.99e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PTEN—urinary bladder cancer	2.74e-06	2.92e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—EP300—urinary bladder cancer	2.68e-06	2.85e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—EP300—urinary bladder cancer	2.61e-06	2.78e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PTEN—urinary bladder cancer	2.56e-06	2.73e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PPARG—urinary bladder cancer	2.46e-06	2.62e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—EP300—urinary bladder cancer	2.44e-06	2.6e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	2.36e-06	2.52e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.93e-06	2.06e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PTEN—urinary bladder cancer	1.69e-06	1.8e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—EP300—urinary bladder cancer	1.61e-06	1.72e-05	CbGpPWpGaD
